Skip to main content
SpringerLink
Log in

Abiraterone

Hormone-sensitive metastatic bone and lymph node flare: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Lu Y. Bone and Lymph Node Flare to Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer on 18F-Prostate-Specific Membrane Antigen PET/CT With Decreasing Prostate-Specific Antigen of 0.7 ng/mL. Clinical Nuclear Medicine 47: 664-665, No. 7, Jul 2022. Available from: URL: http://doi.org/10.1097/RLU.0000000000004107

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abiraterone. Reactions Weekly 1918, 16 (2022). https://doi.org/10.1007/s40278-022-20473-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-20473-7

Search

Navigation